BUSINESS ADVANCEMENT FOR MEDICAL TECHNOLOGY

Mergers and acquisitions represent a corporate strategy through which corporate entities are acquired, divested and combined with one another so as to optimize the potential synergies attainable from such transactions. The preponderance of such transactions are acquisitions, for the sheer fact that it is very rare to have an equitable sharing of leadership between the consolidated corporate entities - instead, one party typically asserts its dominance over the combined corporate entity.

There are extreme variances with respect to the form and function of mergers, acquisitions and divestitures. Certain acquisitions can be construed as friendly, wherein the various corporate entities cooperate in the negotiations with the intended aim of realizing an agreeable combination. Conversely, there are hostile acquisitions, wherein the takeover target is unwilling to be acquired or the target's board of directors has no prior knowledge of the delivered offer - such that the target corporation, its board of directors and/or its shareholders feel pressured into doing that which is not necessarily their preference [hence the hostile nature of such acquisitions].

Divestitures, meanwhile, represent a cleansing of the business operations, wherein a component part of business is sold off to relieve yourself of a now distinguishable business unit, increase your focus on your core competencies or simply to raise capital.

Finally, joint ventures and other forms of strategic partnerships, can enable your business to realize new synergies, whether with 'competitors' or complimentary businesses, while each party effectively retains control of their own business entity.